Drug Trial Radar · NCT07685600
Investigating the Effect of Itraconazole on the Pharmacokinetics of AZD4144 in Healthy Participants
Last checked: Nov 19, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
32
Actual
Start
Jul 30, 2026
Primary completion
Oct 22, 2026
Study completion Oct 22, 2026
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Jul 6, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of the study is to assess the pharmacokinetics (PK) of AZD4144 when administered alone and in combination with itraconazole in healthy participants.
Conditions
- Healthy
Interventions
AZD4144Drug
AZD4144 will be administered orally.
AZD4144Drug
AZD4144 will be administered as an IV infusion.
ItraconazoleDrug
Itraconazole will be administered orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area under concentration time curve from time 0 to infinity (AUCinf)Time frame: Period 1: Day 1 to Day 6; Period 3: Day 10 to Day 16
- Area under concentration curve from time 0 to the last quantifiable concentration (AUClast)Time frame: Period 1: Day 1 to Day 6; Period 3: Day 10 to Day 16
- Maximum observed drug concentration (Cmax)Time frame: Period 1: Day 1 to Day 6; Period 3: Day 10 to Day 16
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Research Site
Harrow, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.